NASDAQ:PCVX

Vaxcyte Stock Insider Trading

Healthcare > Biotechnology

Buy PCVX

*Your capital is at risk

$54.08

-1.88 (-3.36%)

At Close: Jul 31, 2026

Vaxcyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -20.76. In total, the insiders bought 946.55K and sold 288.5K PCVX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-20.76
● Buy	946.55K shares
● Sell	288.5K shares
49% Buy Activity Strong Negative Correlation
Sell Signal Medium Confidence Jul 27, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -20.76. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 02, 2026 Sell	Common Stock F-InKind	Guggenhime Andrew President And CFO	CEO / President	1 009 Value: $62.5K
Mar 02, 2026 Sell	Common Stock F-InKind	Cowan Elvia SVP, Finance & Cao	Officer	326 Value: $20.2K
Feb 28, 2026 Sell	Common Stock F-InKind	Wassil Jim Chief Operating Officer	C-Suite Officer	898 Value: $55.7K
Feb 28, 2026 Sell	Common Stock F-InKind	Pickering Grant Chief Executive Officer	CEO / President	2 863 Value: $177.4K
Feb 28, 2026 Sell	Common Stock F-InKind	Guggenhime Andrew President And CFO	CEO / President	898 Value: $55.7K
Feb 28, 2026 Sell	Common Stock F-InKind	Cowan Elvia SVP, Finance & Cao	Officer	243 Value: $15.1K
Feb 28, 2026 Sell	Common Stock F-InKind	Dhaliwal Harpreet S. Chief Technical Ops Officer	Officer	292 Value: $18.1K
Feb 27, 2026 Sell	Common Stock F-InKind	Wassil Jim Chief Operating Officer	C-Suite Officer	1 900 Value: $117.3K
Feb 27, 2026 Buy	Common Stock A-Award	Wassil Jim Chief Operating Officer	C-Suite Officer	5 102 Value: $315.0K
Feb 26, 2026 Buy	Common Stock A-Award	Wassil Jim Chief Operating Officer	C-Suite Officer	32 045 Value: $1.92M
Feb 26, 2026 Buy	Stock Option (right to buy) A-Award	Dhaliwal Harpreet S. Chief Technical Ops Officer	Officer	46 424 Value: $2.79M
Feb 26, 2026 Buy	Stock Option (right to buy) A-Award	Pickering Grant Chief Executive Officer	CEO / President	175 698 Value: $10.5M
Feb 26, 2026 Buy	Common Stock A-Award	Pickering Grant Chief Executive Officer	CEO / President	105 110 Value: $6.31M
Feb 26, 2026 Buy	Stock Option (right to buy) A-Award	Guggenhime Andrew President And CFO	CEO / President	74 993 Value: $4.50M
Feb 26, 2026 Buy	Common Stock A-Award	Guggenhime Andrew President And CFO	CEO / President	44 864 Value: $2.69M
Feb 26, 2026 Buy	Stock Option (right to buy) A-Award	Cowan Elvia SVP, Finance & Cao	Officer	17 855 Value: $1.07M
Feb 26, 2026 Buy	Stock Option (right to buy) M-Exempt	Cowan Elvia SVP, Finance & Cao	Officer	7 716 Value: $200.0K
Feb 26, 2026 Buy	Common Stock M-Exempt	Cowan Elvia SVP, Finance & Cao	Officer	7 716 Value: $200.0K
Feb 26, 2026 Buy	Common Stock A-Award	Cowan Elvia SVP, Finance & Cao	Officer	10 681 Value: $640.9K
Feb 26, 2026 Buy	Common Stock A-Award	Dhaliwal Harpreet S. Chief Technical Ops Officer	Officer	53 409 Value: $3.20M
Feb 26, 2026 Buy	Stock Option (right to buy) A-Award	Wassil Jim Chief Operating Officer	C-Suite Officer	53 566 Value: $3.21M
Jan 15, 2026 Buy	Stock Option (right to buy) A-Award	Brandicourt Olivier Director	Director	6 750 Value: $324.3K
Jan 14, 2026 Sell	Common Stock G-Gift	Pickering Grant Chief Executive Officer	CEO / President	100 000 Value: $0
Jan 14, 2026 Sell	Common Stock G-Gift	Guggenhime Andrew President And CFO	CEO / President	61 850 Value: $0
Jan 14, 2026 Buy	Common Stock G-Gift	Guggenhime Andrew President And CFO	CEO / President	61 850 Value: $3.00M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VAXCYTE, INC.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co...

Read Full Profile Here